Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

19 May 2022 10:27

RNS Number : 1108M
Mandarin Oriental International Ltd
19 May 2022
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

19th May 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2022.

 

Trading conditions in the period improved in most parts of the world compared to the first quarter of 2021. Government restrictions on international and domestic travel, however, hampered the operating performance in Asia, with properties in China being particularly affected, and these challenges have continued into the second quarter.

 

In Europe, Middle East and Africa ('EMEA') and America, occupancy levels were lower than pre-pandemic levels for most properties, but room rates have held up well and are generally higher than in 2019. In Asia, both occupancy and room rates have remained substantially below pre-pandemic levels.

 

During the first quarter, the Group announced three new properties, in the Maldives, Costa Navarino and Cairo, increasing the Group's pipeline of new hotels and residences under development to 25.

 

The Group recorded an EBITDA loss of US$1 million in the first quarter. The impact of continued travel restrictions in much of Asia was offset by a more robust performance in EMEA and America and tightly-controlled corporate costs. Owned hotels and the management business recorded an underlying EBITDA loss of US$6 million and an underlying EBITDA profit of US$5 million, respectively.

 

Underlying losses (unaudited) for the Group were much improved compared to 2021, with the management business recording a marginal underlying profit (unaudited) in the period. As noted in the Group's 2021 full year results in March 2022, the outlook continues to improve in most markets, but there remains uncertainty in relation to China.

 

The Group's financial position is robust. Net debt at 31st March 2022 was US$542 million, and the Group held US$159 million of cash reserves and US$317 million in available, committed debt facilities. Gearing was 11% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley 

(852) 2895 9288

Matthew Bishop 

(852) 2895 9288

Brunswick Group Limited

Sunitha Chalam

(65) 6426 8188

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKKLBFLELLBBZ
Date   Source Headline
29th May 202610:53 amRNSTotal Voting Rights
29th May 202610:47 amRNSDirector/PDMR Shareholding
28th May 202611:31 amRNSTransaction in Own Shares
27th May 202610:27 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSAcquisition of I-MED Radiology Network
22nd May 202610:23 amRNSInterim Management Statement
19th May 202612:22 pmRNSINTERIM MANAGEMENT STATEMENT
18th May 202612:57 pmRNSNotification of Issuance of Equity Securities
18th May 202612:30 pmRNSDirector/PDMR Shareholding
7th May 20261:01 pmRNSAdditional Listing
7th May 202612:49 pmRNSDirector/PDMR Shareholding
7th May 202612:44 pmRNSResult of AGM
5th May 202610:54 amRNSTransaction in Own Shares
5th May 202610:19 amRNSTransaction in Own Shares
30th Apr 202611:51 amRNSTotal Voting Rights
30th Apr 202611:50 amRNSTransaction in Own Shares
30th Apr 202610:47 amRNSJC&C Interim Management Statement
29th Apr 202612:28 pmRNSPT Astra 2026 First Quarter Financial Statements
29th Apr 202611:59 amRNSTransaction in Own Shares
29th Apr 202610:48 amRNSDividend
28th Apr 202611:35 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202611:26 amRNSDividend
22nd Apr 202611:12 amRNSTransaction in Own Shares
21st Apr 202610:57 amRNSTransaction in Own Shares
20th Apr 202611:01 amRNSTransaction in Own Shares
14th Apr 202611:31 amRNSTransaction in Own Shares
13th Apr 202611:27 amRNSTransaction in Own Shares
10th Apr 202611:23 amRNSTransaction in Own Shares
8th Apr 202611:53 amRNSTransaction in Own Shares
8th Apr 202610:25 amRNSAnnual Financial Report
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20268:02 amRNSTransaction in Own Shares
1st Apr 202611:17 amRNSTransaction in Own Shares
1st Apr 202610:34 amRNSCirc re. Scrip Dividend Scheme
1st Apr 202610:21 amRNSDirector/PDMR Shareholding
31st Mar 202611:59 amRNSDirector/PDMR Shareholding
31st Mar 202611:53 amRNSTotal Voting Rights
31st Mar 202611:46 amRNSTransaction in Own Shares
30th Mar 202611:08 amRNSTransaction in Own Shares
27th Mar 20269:43 amRNSDirector/PDMR Shareholding
25th Mar 202611:05 amRNSDirector/PDMR Shareholding
25th Mar 202610:31 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 202611:07 amRNSTransaction in Own Shares
20th Mar 20269:26 amRNSDirector/PDMR Shareholding
17th Mar 20269:55 amRNSDirector/PDMR Shareholding
16th Mar 20269:57 amRNSDirector/PDMR Shareholding
16th Mar 20269:57 amRNSDirector/PDMR Shareholding
13th Mar 20269:42 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.